KAMADA LTD (KMDA) Stock Fundamental Analysis
NASDAQ:KMDA - IL0010941198 - Common Stock
6.92 USD
-0.1 (-1.42%)
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 547 industry peers in the Biotechnology industry. KMDA scores excellent on profitability, but there are some minor concerns on its financial health. KMDA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make KMDA a good candidate for value investing.
1. Profitability
1.1 Basic Checks
KMDA had positive earnings in the past year.
In the past year KMDA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA has a Return On Assets of 5.16%. This is amongst the best in the industry. KMDA outperforms 91.22% of its industry peers.
KMDA's Return On Equity of 7.31% is amongst the best of the industry. KMDA outperforms 92.32% of its industry peers.
KMDA has a Return On Invested Capital of 6.18%. This is amongst the best in the industry. KMDA outperforms 93.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 16.04%.
The last Return On Invested Capital (6.18%) for KMDA is above the 3 year average (2.98%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROIC | 6.18% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 11.21%, KMDA belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
KMDA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 14.89%, KMDA belongs to the best of the industry, outperforming 93.97% of the companies in the same industry.
KMDA's Operating Margin has declined in the last couple of years.
KMDA has a Gross Margin of 43.62%. This is in the better half of the industry: KMDA outperforms 75.14% of its industry peers.
In the last couple of years the Gross Margin of KMDA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KMDA is destroying value.
KMDA has about the same amout of shares outstanding than it did 1 year ago.
KMDA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KMDA is higher compared to a year ago.
2.2 Solvency
KMDA has an Altman-Z score of 3.28. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.28, KMDA is in the better half of the industry, outperforming 73.86% of the companies in the same industry.
The Debt to FCF ratio of KMDA is 0.36, which is an excellent value as it means it would take KMDA, only 0.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.36, KMDA belongs to the top of the industry, outperforming 95.80% of the companies in the same industry.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of KMDA (0.04) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | 3.28 |
ROIC/WACC0.71
WACC8.72%
2.3 Liquidity
A Current Ratio of 4.00 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a Current ratio (4.00) which is comparable to the rest of the industry.
A Quick Ratio of 2.21 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a worse Quick ratio (2.21) than 70.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.93%, which is quite impressive.
Measured over the past years, KMDA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.60% on average per year.
KMDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.67%.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
3.2 Future
The Earnings Per Share is expected to grow by 30.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 9.38% on average per year.
EPS Next Y37.31%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.38%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.35, the valuation of KMDA can be described as rather expensive.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.33% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of KMDA to the average of the S&P500 Index (27.17), we can say KMDA is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.03 indicates a correct valuation of KMDA.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.33% of the companies in the same industry.
KMDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.35 | ||
| Fwd PE | 16.03 |
4.2 Price Multiples
96.71% of the companies in the same industry are more expensive than KMDA, based on the Enterprise Value to EBITDA ratio.
97.08% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.64 | ||
| EV/EBITDA | 8.77 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
KMDA's earnings are expected to grow with 30.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.79%, KMDA has a reasonable but not impressive dividend return.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 96.44. KMDA pays more dividend than 98.35% of the companies in the same industry.
KMDA's Dividend Yield is comparable with the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.79% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
NASDAQ:KMDA (8/29/2025, 4:30:02 PM)
6.92
-0.1 (-1.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners10.31%
Inst Owner Change11.91%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap399.15M
Analysts84.44
Price Target16.32 (135.84%)
Short Float %0.15%
Short Ratio0.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.79% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.64%
Min EPS beat(2)1.67%
Max EPS beat(2)41.61%
EPS beat(4)4
Avg EPS beat(4)18.73%
Min EPS beat(4)1.67%
Max EPS beat(4)41.61%
EPS beat(8)7
Avg EPS beat(8)31.4%
EPS beat(12)10
Avg EPS beat(12)19.06%
EPS beat(16)10
Avg EPS beat(16)-93.75%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.83%
Revenue beat(12)4
Avg Revenue beat(12)-0.46%
Revenue beat(16)5
Avg Revenue beat(16)0.27%
PT rev (1m)8.47%
PT rev (3m)8.47%
EPS NQ rev (1m)2.78%
EPS NQ rev (3m)32.14%
EPS NY rev (1m)6.87%
EPS NY rev (3m)17.65%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.35 | ||
| Fwd PE | 16.03 | ||
| P/S | 2.35 | ||
| P/FCF | 12.64 | ||
| P/OCF | 9.95 | ||
| P/B | 1.54 | ||
| P/tB | 1.74 | ||
| EV/EBITDA | 8.77 |
EPS(TTM)0.34
EY4.91%
EPS(NY)0.43
Fwd EY6.24%
FCF(TTM)0.55
FCFY7.91%
OCF(TTM)0.7
OCFY10.05%
SpS2.94
BVpS4.51
TBVpS3.98
PEG (NY)0.55
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROCE | 7.83% | ||
| ROIC | 6.18% | ||
| ROICexc | 7.78% | ||
| ROICexgc | 8.82% | ||
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% | ||
| FCFM | 18.63% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 58.03% | ||
| Cap/Sales | 5.03% | ||
| Interest Coverage | 35.45 | ||
| Cash Conversion | 100.46% | ||
| Profit Quality | 166.16% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 | ||
| Altman-Z | 3.28 |
F-Score6
WACC8.72%
ROIC/WACC0.71
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
EPS Next Y37.31%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.38%
Revenue Next 5YN/A
EBIT growth 1Y50%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year124.05%
EBIT Next 3Y35.88%
EBIT Next 5YN/A
FCF growth 1Y387.49%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y257.57%
OCF growth 3YN/A
OCF growth 5Y11.54%